ABSTRACT
Immune checkpoint inhibitors have transformed the management of patients with metastatic urothelial cancer, by leading to long-term response and prolongation of survival in a subset of patients. Unfortunately, only one in five patients with metastatic urothelial cancer responds to anti-programmed death ligand-1 ([AQ1]anti-PD-1) monotherapy. Preclinical and early clinical evidence indicates that radiotherapy not only acts locally, but also exerts systemic anti-tumour effects by modulating the immune system. It is hypothesised that combining checkpoint inhibitors with radiotherapy might enhance an anti-tumour immune response and increase response rates. So far, a handful of early phase clinical trials have been performed seeking to answer this question in urothelial cancer patients. The current review summarises the available preclinical and clinical evidence on radiotherapy/immunotherapy combinations in locally advanced and metastatic bladder cancer and suggests future avenues worthy of exploration.
Subject(s)
Immunotherapy , Urinary Bladder Neoplasms , B7-H1 Antigen , Combined Modality Therapy , Humans , Programmed Cell Death 1 Receptor , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/radiotherapySubject(s)
Carcinoma, Transitional Cell/secondary , Factor X Deficiency/etiology , Lung Neoplasms/secondary , Neoplasm Metastasis/physiopathology , Urinary Bladder Neoplasms/complications , Aged , Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Agents, Immunological/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Blood Coagulation Tests , Carcinoma, Transitional Cell/complications , Carcinoma, Transitional Cell/therapy , Combined Modality Therapy , Cystectomy , Factor X Deficiency/blood , Humans , Lung Neoplasms/complications , Lung Neoplasms/therapy , Male , Neoadjuvant Therapy , Radiosurgery , Urinary Bladder Neoplasms/therapyABSTRACT
Alcohol abuse is a major health concern. The aim of this retrospective study was to analyse the alcohol-related emergency department (ED) admissions among adolescents in all hospitals of distinct areas during a 1-year period. In each hospital, all ED patients with a blood alcohol concentration (BAC) of at least 0.5âg/l were surveyed in a standardised way. Of the 3918 included patients, only 146 (3.7%) were < 18 âyears. The male-to-female ratio was 1.5:1. There was a strong preponderance of weekend and night time admissions. Most of the patients were transported by ambulance (77% of 138 patients with information on this item). The main reason for ED admittance was depressed level of consciousness (64%), trauma (12%), vomiting and/or abdominal pain (12%), agitation or aggression (4%), syncope (4%) and psychological problems (4%). The context of the alcohol intoxication was related to some kind of festivity in 85%, mental problems in 14% and chronic abuse in 1%. Median BAC values (and range) were 2.08âg/l (0.73-3.70âg/l) for boys and 1.51âg/l (0.73-2.90âg/l) for girls. Most patients (87%) could be discharged home within 24 âhours. Our study confirms that problematic alcohol use leading to ED admissions starts in adolescence. Although the numbers of cases below 18âyears are low when compared to adults, the phenomenon is alarming as it is associated with substantial health problems. Therefore, Belgium urgently needs a global national alcohol plan, with youngsters being one of the target groups.